Table 3.
Mutation | L113P | G183V | L226F | M233L | R352ins |
---|---|---|---|---|---|
Disease phenotype | FTD-like dementia | Pick’s disease | EOAD and FTD-like phenotypes | FTD-like dementia | FTD, but pathogenic nature unclear |
Age at onset | 38–52 years | 52 years | 33–37 years | 39 years | Unknown |
Family history | Positive | Positive | Positive or de novo | Unknown, no affected family members found | Unknown |
Symptoms | Personality- and behavioral changes, spatial orientation | Personality changes: apathy, overeating, or frontal disinhibition | Behavioral changes; nonfluent aphasia; cognitive decline; Parkinsonism; rapid progress to death | Behavioral changes: became detached and disengaged in daily activities, impairment in communication, overeating, became paranoid | FTD |
Neuroimaging | CT: frontotemporal atrophy SPECT: hypoperfusion in the frontal lobes | Severe atrophy in the frontotemporal lobes Pick bodies and Tau-positive inclusions, without Aβ deposits | Frontal- and cortical atrophy FDG-PET: cortical hypometabolism especially in bilateral parietal regions | PET: hypoperfusion and hypometabolism in the posterior parietal areas, and in prefrontal, parietal, and temporal cortex, respectively | Ubiquitin-positive but Tau-negative form of FTD |
Abbreviations: FTD, frontemporal dementia; EOAD, early onset Alzheimer’s disease; CT, computed tomography; SPECT, Single-photon emission computed tomography; FDG-PET, Single-photon emission computed tomography.